Latest News and Press Releases

VTP-1000, an antigen-specific immunotherapy to treat celiac disease, showed a dose-dependent pharmacological effect in the SAD portion of the trialVTP-1000 was well-tolerated with no treatment-related...

Single ascending dose data readout for VTP-1000 expected before the end of 2025Enrollment advancing in multiple ascending dose part of the AVALON trial; data expected in the second half of...

Prioritizing VTP-1000 development in celiac disease, Phase 1 data expected in mid-2025Postponing further clinical development of VTP-300 in chronic hepatitis B (CHB) until a partner is...

Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results

Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

MISSISSAUGA, Ontario, May 16, 2022 (GLOBE NEWSWIRE) -- On Celiac Disease Awareness Day, the Canadian Celiac Association (CCA) says as many as 400,000 Canadians could be living with the auto-immune...

RACINE, Wis., Jan. 10, 2022 (GLOBE NEWSWIRE) -- MYBREAD® Gluten Free Bakery, a dedicated gluten-free bakery located in Racine, Wis., has launched their Original Flatbread Pitas at select Walmart...

Philadelphia, PA, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, will host its 2021 Virtual Step Beyond Celiac 5K on September...

Philadelphia, PA, Aug. 16, 2021 (GLOBE NEWSWIRE) -- The gluten-free diet is currently the only treatment for celiac disease, but it is far from a complete and effective intervention. That’s the...

Philadelphia, PA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading accelerator for a celiac disease cure in the United States, is pleased to support the Food Labeling Modernization Act...